aod9604 acetate AOD-9604 (10 MG) AOD 9604 Peptide | Metabolic

Conclusion Whilst severe B12 deficiency has a clear clinical picture with characteristic haematological and/or neurological features, establishing mild or borderline deficiency can be problematic as serum levels are maintained at the expense of tissue concentrations, and therefore serum levels of B12 may be in the low normal or borderline range despite a deficiency

Most metabolic peptides require subcutaneous injection, creating compliance barriers for chronic conditions like obesity

Injection frequency: AOD 9604 requires daily injection

It has been observed to upregulate genes associated with tissue repair and antioxidant defense while downregulating genes linked to inflammation and fibrosis